A Real-world Non-interventional Study to Assess Patient Satisfaction With and Preference for Re-usable Respimat Soft Mist Inhaler in Patients With Chronic Obstructive Pulmonary Disease
Latest Information Update: 04 Mar 2021
At a glance
- Drugs Olodaterol (Primary) ; Olodaterol/tiotropium bromide (Primary) ; Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
Most Recent Events
- 19 Feb 2020 Status changed from active, no longer recruiting to completed.
- 22 Jan 2020 Planned End Date changed from 3 Feb 2020 to 11 Feb 2020.
- 22 Jan 2020 Planned primary completion date changed from 3 Feb 2020 to 11 Feb 2020.